Health leaders rally for a national awakening on prevention, mental wellness, and lifestyle reform at ‘Illness to Wellness’ heart care conference
An estimated 50% of patients with ER+, HER2– metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor
Air Liquide will provide care for people living with respiratory diseases such as chronic obstructive pulmonary disease (COPD) and sleep apnea
ITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), KENGREAL of Chiesi USA
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
These filings come after FDA issued its latest warning to patients and healthcare professionals about the serious dangers of compounded GLP-1 drugs
This marks the fourth acquisition by Corona Remedies from multinational corporations
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Subscribe To Our Newsletter & Stay Updated
